Science Market Update

Berkeley Researchers Team Up for $7.5M Immunotherapy Initiative

Posted by Laura Braden on Thu, Apr 21, 2016

The University of California, Berkeley is a leading research institution, producing promising research in all divsions of the life sciences. To help further research in immunotherapy and cancer, researchers from the University of California, Berkeley have recently teamed up with the Berkeley-based biotech company, Aduro Biotech Inc., for a $7.5 million immunotherapy initiative. This Immunotherapeutics and Vaccine Research Initiative (IVRI) will provide three years of funding to infectious disease researchers studying new techniques for combating both infections and cancer.  

Read More

Tags: CA, University of California Berkeley, immunotherapy, cancer research, vaccine research, Southwest, researchers, UC Berkeley, new funding, UCBerk, 2016, BioResearch Product Faire, Aduro Biotech

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News